Page last updated: 2024-11-10

metaphosphoric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

metaphosphoric acid: RN given refers to cpd with structure HPO3 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

phosphonate(1-) : A monovalent inorganic anion obtained by deprotonation of one of the two OH groups in phosphonic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3084658
CHEBI ID33462
CHEBI ID195297
MeSH IDM0128287

Synonyms (34)

Synonym
phosphoric acid meta
unii-mtk99r3uv0
mtk99r3uv0 ,
einecs 253-433-4
phosphenic acid
hydrogen phosphonate
[pho2(oh)](-)
hydrogenphosphonate
CHEBI:33462
phosphonate(1-)
hydridohydroxidodioxidophosphate(1-)
metaphosphoric acid
37267-86-0
CHEBI:195297
metaphosphoric acid (hpo3)
einecs 233-750-4
10343-62-1
meta-phosphoric acid
FT-0628262
AKOS015893002
meta-phosphoric acid, puriss. p.a., acs reagent, >=33.5% (t)
meta-phosphoric acid, purum, ~65% hpo3 basis, pieces
mfcd00011351
metaphosphoric acid, 39-43%, bal. napo3 (stabilizer)
meta-phosphoric acid, acs reagent, chips, 33.5-36.5%
meta-phosphoric acid, saj special grade, >=37.0% hpo3 basis
meta-phosphoric acid, 100%, lumps (glassy)
meta-phosphoric acid, vetec(tm) reagent grade
meta-phosphoric acid, bioxtra, >=33.5%
DTXSID10893985
hydrogen phosphonate ion
Q27115658
Q2622702
m phosphoric acid

Research Excerpts

Overview

Metaphosphoric acid proved to be a good mimetic of the metaphosphate intermediate and facilitated the ready and rapid evaluation by NMR spectroscopic analysis of a dissociative mechanism.

ExcerptReferenceRelevance
"Metaphosphoric acid proved to be a good mimetic of the metaphosphate intermediate and facilitated the ready and rapid evaluation by NMR spectroscopic analysis of a dissociative mechanism."( Study of the Phosphoryl-Transfer Mechanism of Shikimate Kinase by NMR Spectroscopy.
Beceiro, A; González-Bello, C; Hawkins, AR; Lence, E; Prado, V; Thompson, P; Vallejo, JA, 2016
)
1.16
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (44)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (18.18)18.7374
1990's6 (13.64)18.2507
2000's18 (40.91)29.6817
2010's10 (22.73)24.3611
2020's2 (4.55)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 58.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index58.00 (24.57)
Research Supply Index3.89 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index92.52 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (58.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (95.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]